Zogenix and Battelle Launch "Less is More" DosePro(R) Marketing Campaign
The goal of the campaign is to emphasize the simplicity and benefits of the DosePro technology and its ability to provide instantaneous, needle-free, subcutaneous drug delivery. The first phase of the DosePro marketing campaign was launched at the 2012
The companies completed the roll out of the marketing campaign with the launch of www.DosePro.com and the continued direct-to-client marketing strategies by Battelle. The new DosePro website features video on the needle-free delivery technology, additional information including system specifications, and recent presentations on the DosePro technology given at conferences across
Battelle's business development professionals responsible for health and life sciences will continue to market DosePro to their clients in strategic product planning meetings, at future conferences, in trade publications, and through other marketing communications. For more information on licensing opportunities using the DosePro platform contact Battelle at 1-800-201-2011 or firstname.lastname@example.org.
The DosePro system is a first-in-class, easy-to-use drug delivery system designed for self-administration of a pre-filled, single dose of sterile liquid drug, subcutaneously, without a needle. The platform is currently used by
For additional information, please visit www.zogenix.com.
As the world's largest independent research and development organization, Battelle provides innovative solutions to the world's most pressing needs through its four global businesses: Laboratory Management;
Battelle also is one of the nation's leading charitable trusts focusing on societal and economic impact, and actively supporting and promoting science, technology, engineering and mathematics (STEM) education.
Forward Looking Statements
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and
SUMAVEL®, DosePro®, ReldayTM and ZohydroTM are trademarks of
CONTACT: Zogenix Investor Contact
The Ruth Group Zack Kubow646.536.7020 | email@example.com Zogenix Media Contact The Ruth Group Victoria Aguiar646.536.7013 | firstname.lastname@example.org Battelle Contacts: Katy Delaney614.424.7208 | email@example.com T.R. Massey614.424.5544 | firstname.lastname@example.org